AF/LE Purified Anti-Human CD19 Antibody[HI19a]
规格: | |
价格: |
货号:E-AB-F13040P
货期:咨询
宿主: Mouse
反应性: H
应用: FCM
Overview
Synonyms | Antibody deficiency due to defect in CD19;included;AW495831;B lymphocyte antigen CD19;B lymphocyte surface antigen B4;B-lymphocyte antigen CD19;B-lymphocyte surface antigen B4;B4;CD19;CD19 antigen;CD19 molecule;Cd19 protein;CD19;CVID3;Differentiation antigen CD19;Leu 12;Leu-12;Leu12;MGC109570;MGC12802;T-cell surface antigen Leu-12 |
Swissprot | P15391 |
Source | Mouse |
Reactivity | Human |
Immunogen | Recombinant Human CD19 protein |
Application | FCM |
Recommended dilution | FCM,,2 μg/mL(1×10^5-5×10^5 cells) |
Concentration | 1mg/mL |
Clonality | Monoclonal |
Properties
Clone No | HI19a |
---|---|
Isotype | Mouse IgG1, κ |
Purification | >98%, Protein A/G purified |
Conjugation | Unconjugated |
Storage instructions | Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions. |
Storage buffer | Sterile PBS. < 1.0 EU per mg of the antibody as determined by the LAL method |
Background | CD19 is a B cell–specific molecule that controls B cell activation by complexing with the BCR. CD19 is a member of the Ig superfamily and is the dominant component for the signaling complex on B cells that includes CD21,CD81,and CD22. Humans with CD19 deficiency have reduced proliferative responses to BCR stimulation in vitro and mount impaired Ab responses to vaccination. |